

HY-161700 · 50 mg
MedChemExpress · Cat: HY-161700
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bms-737.html
Description
BMS-737 compound 33 is a non-steroidal, reversible small molecule inhibitor. BMS-737 exhibits 11-fold selectivity for CYP17 lyase over CYP17 hydroxylase. BMS-737 is designed to inhibit castration-resistant prostate cancer CRPC and significantly reduces testosterone levels without significant effects on orrodermal hormone and glucocorticoid levels.







